Table 4.
Time to Completion, Cox Proportional Hazard Models
| HSP | Rural Border Counties | Hispanic/ Latinx |
American Indian |
Less than High School Education |
Teen Mother | Firstborn | |
|---|---|---|---|---|---|---|---|
| All Shots | 1.13*** | 1.18*** | 1.15*** | 1.08 | 1.14*** | 1.14* | 1.12*** |
| (1.08, 1.18) | (1.10, 1.26) | (1.09, 1.21) | (0.96, 1.21) | (1.05, 1.22) | (1.03, 1.26) | (1.05, 1.19) | |
| HepB | 1.11*** | 1.13*** | 1.11*** | 1.09 | 1.10** | 1.17*** | 1.09** |
| (1.08, 1.16) | (1.07, 1.20) | (1.06, 1.16) | (0.98, 1.20) | (1.04, 1.18) | (1.07, 1.27) | (1.03, 1.15) | |
| DTaP/DTP | 1.10*** | 1.15*** | 1.11*** | 1.09 | 1.11** | 1.09* | 1.05 |
| (1.06, 1.14) | (1.08, 1.22) | (1.06, 1.17) | (0.99, 1.21) | (1.04, 1.18) | (1.00, 1.19) | (0.99, 1.11) | |
| Hib | 1.14*** | 1.12*** | 1.13*** | 1.13* | 1.14*** | 1.11* | 1.11*** |
| (1.09, 1.18) | (1.05, 1.19) | (1.08, 1.19) | (1.02, 1.26) | (1.07, 1.22) | (1.01, 1.21) | (1.04, 1.17) | |
| PCV13 | 1.14*** | 1.15*** | 1.14*** | 1.15* | 1.15*** | 1.16** | 1.13*** |
| (1.10, 1.18) | (1.08, 1.22) | (1.08, 1.19) | (1.03, 1.29) | (1.07, 1.23) | (1.06, 1.27) | (1.06, 1.19) | |
| Polio | 1.10*** | 1.14*** | 1.12*** | 1.08 | 1.11** | 1.13** | 1.07* |
| (1.07, 1.14) | (1.08, 1.21) | (1.07, 1.17) | (0.97, 1.19) | (1.04, 1.18) | (1.04, 1.23) | (1.01, 1.13) | |
| MMR | 1.10*** | 1.12*** | 1.09*** | 1.11* | 1.12*** | 1.13** | 1.07* |
| (1.06, 1.14) | (1.06, 1.19) | (1.05, 1.14) | (1.00, 1.22) | (1.05, 1.19) | (1.04, 1.23) | (1.01, 1.13) | |
| Varicella | 1.11*** | 1.13*** | 1.11*** | 1.13* | 1.15*** | 1.16*** | 1.09** |
| (1.08, 1.15) | (1.06, 1.20) | (1.06, 1.16) | (1.02, 1.24) | (1.08, 1.22) | (1.07, 1.26) | (1.03, 1.15) |
Hazard ratios associated with HSP participation (intervention) indictor, 95% CIs reported in parentheses. Estimation population is limited to HSP participants and matches, and weighted using weight based on number of matches and intervention persons within propensity score value.
* p < 0.05; ** p < 0.01; *** p < 0.001.